Chinese Journal of Pharmacovigilance ›› 2020, Vol. 17 ›› Issue (12): 904-906.
DOI: 10.19803/j.1672-8629.2020.12.12

Previous Articles     Next Articles

157 Cases of Adverse Drug Reactions Induced by Iopromide Injection

CHENG Xiaoping1, ZHU yajian2, LIU Xueliang3   

  1. 1Center for ADR Monitoring of Qinghai,Xining Qinghai 810007,China;
    2Qinghai Provincial Drug Administration,Xining Qinghai 810007,China;
    3Qinghai Food and Drug Administration Technical Evaluation Center,Xining Qinghai 810007,China
  • Received:2020-05-06 Revised:2020-12-07 Online:2020-12-15 Published:2020-12-07

Abstract: Objective To explore the clinical characteristics and regularity of adverse reactions (ADR) caused by iopromide injection so as to provide reference for reducing the risk of clinical medication.Methods The ADR reports of 157 cases of iopromide injection collected between 2009 and 2019 from the provincial database of the national adverse drug reaction monitoring system were statistically analyzed using the retrospective research method.Results ADRs caused by iopromide injection were more common among females than among males, and 68.16% of the ADRS occurred within 30 minutes of medication. The dominating clinical manifestations were the damage to the skin and its accessories, and anaphylactic shock was the most serious consequence.Conclusion In order to ensure the safety of drug use, drug instructions should be strictly observed clinically. Attention should be paid to the serious adverse reactions before and after drug use so as to identify and prevent ARDs as soon as possible and reduce the incidence of ADRs related to this injection.

Key words: lopromide injection, adverse drug reactions, rational drug application

CLC Number: